Tumour markers in prostate cancer III: Biomarkers in urine

Evaluation of the ETS-Related Gene mRNA in Urine for the Detection of Prostate Cancer

(2010) K. R. Rice et al.   CLINICAL CANCER RESEARCH

Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours

(2010) Florian Jentzmik et al.   EUROPEAN UROLOGY

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

(2010) Jonas Hugosson et al.   LANCET ONCOLOGY

Urine biomarkers in prostate cancer

(2010) Guillaume Ploussard et al.   Nature Reviews Urology

Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer

(2009) E A M Heijnsdijk et al.   BRITISH JOURNAL OF CANCER

Urine Analysis and Protein Networking Identify Met as a Marker of Metastatic Prostate Cancer

(2009) A. L. Russo et al.   CLINICAL CANCER RESEARCH

Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

(2009) Monique J. Roobol et al.   EUROPEAN UROLOGY

Multicenter Evaluation of an Investigational Prostate Cancer Methylation Assay

(2009) Jonathan Baden et al.   JOURNAL OF UROLOGY

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

(2009) Arun Sreekumar et al.   NATURE

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

DNA methylation biomarkers of prostate cancer: Confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection

(2009) Shannon R. Payne et al.   PROSTATE

Identification of extracellular δ-catenin accumulation for prostate cancer detection

(2009) Qun Lu et al.   PROSTATE

Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer

(2009) Daphne Hessels et al.   PROSTATE

Urinary Prostate Cancer 3 Test: Toward the Age of Reason?

(2009) Virginie Vlaeminck-Guillem et al.   UROLOGY

The Role of SPINK1 in ETS Rearrangement-Negative Prostate Cancers

(2008) Scott A. Tomlins et al.   CANCER CELL

A First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer

(2008) B. Laxman et al.   CANCER RESEARCH

Tumor-Specific Urinary Matrix Metalloproteinase Fingerprinting: Identification of High Molecular Weight Urinary Matrix Metalloproteinase Species

(2008) R. Roy et al.   CLINICAL CANCER RESEARCH

Development of a Multiplexed Urine Assay for Prostate Cancer Diagnosis

(2008) T. Vener et al.   CLINICAL CHEMISTRY

Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy

(2008) Alexander Haese et al.   EUROPEAN UROLOGY

IMPROVED PREDICTION OF PROSTATE BIOPSY OUTCOME USING PCA3, TMPRSS2:ERG GENE FUSIONS AND SERUM PSA

(2008) Sheila M Aubin et al.   JOURNAL OF UROLOGY

PCA3 Score Before Radical Prostatectomy Predicts Extracapsular Extension and Tumor Volume

(2008) Eric J. Whitman et al.   JOURNAL OF UROLOGY

PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy Outcome

(2008) Ina L. Deras et al.   JOURNAL OF UROLOGY

Annexin A3 in Urine: A Highly Specific Noninvasive Marker for Prostate Cancer Early Detection

(2008) Martin Schostak et al.   JOURNAL OF UROLOGY